News and Announcements
BPS Completes Funds Raising and Acquisitions
- Published December 14, 2015 4:59PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
14th December 2015, ASX Announcement
BPS Technology Limited (“BPS”) (ASX:BPS) is pleased to announce it has finalised the issue and placement of Convertible Notes at $1.175 per share conversion ratio and raising a total of $5 million on terms favourable to the Company.
Key highlights:
- Strongly supported institutional placement
- Three new Listed Investment Companies join the register
- Funding for earnings accretive acquisitions
The proceeds will be used to fund earnings accretive acquisitions and to further accelerate merchant growth in our key strategic areas.
BPS can announce that these new funds have, in part, been immediately applied to the purchase of two additional key Bartercard Franchise territories. In doing so, this will accelerate the joining of new merchants and assist in the rollout of the bucqi payments and loyalty platform which is currently being launched in selected areas within Queensland.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
